A Nobel Prize-winning Scots chemist has said he believes drugs to treat Alzheimer’s disease could be available within five years ...

Eisai has presented new clinical data showing that patients with early Alzheimer’s disease continue to benefit from four years of treatment with Leqembi (lecanemab). Findings were shared at the ...

New research results reported at the Alzheimer's Association International Conference® 2025 (AAIC®) advanced scientific ...

In an exciting breakthrough, researchers have identified cancer drugs that might reverse the effects of Alzheimer's disease ...